Some Glucosyl- and Ribosyl-Pyridazin-3-ones
191
6. Rastogi, V. K.; Parmar, S. S.; Singh, S. P.; Akers, T. K. Synthesis of 2-methyl-3-(3,5-diallyl-4-
hydroxyphenyl)-4-quinazolones as possible anticonvulsants. J. Heterocyclic Chem. 1978, 15, 497–499.
7. Wolfe, J. F.; Rathman, T. L.; Sleevi, M. C.; Cambpell, J. A.; Greenwood, T. D. Synthesis and
anticonvulsant activity of some new 2-substituted 3-aryl-4(3H)-quinazolinones. J. Med. Chem. 1990,
33, 161–166.
8. Melikian, A.; Schlewer, G.; Chambon, J. P.; Wermuth, C. G. Condensation of muscimol or thiomus-
cimol with aminopyridazines yields GABA-A antagonists. J. Med. Chem. 1992, 35, 4092–4097.
9. Lee, S. J.; Konishi, Y.; Yu, D. T.; Miskowski, T. A.; Riviello, C. M.; Macina, O. T.; Frierson, ??; Kondo, M.
R.K.; Sugitani, M.; Sircar, J. C.; Blazejewski, K. M. Discovery of potent cyclic GMP phosphodiesterase
inhibitors. 2-Pyridyl- and 2-imidazolylquinazolines possessing cyclic GMP phosphodiesterase and
thromboxane synthesis inhibitory activities. J. Med. Chem. 1995, 38, 3547–3557.
10. Levin, J. I.; Venkatesan, A. M. U. S. Patent No. 5, 284, 853-A,1994.
11. Kurogi, Y.; Inoue, Y.; Tsutsumi, K.; Nakamura, S.; Nagao, k.; Yoshitsugu, H.; Tsuda, Y. Synthesis
and hypolipidemic activities of novel 2-[4-[(diethoxyphosphoryl)methyl]phenyl]quinazolines and
4(3H)-quinazolinones. J. Med. Chem. 1996, 39, 1433–1437.
12. Jiang, J. B.; Hesson, D. P.; Dusak, B. A.; Dexter, D. L.; Kangand, G. J.; Hamel, E. Synthesis and
biological evaluation of 2-styrylquinazolin-4(3H)-ones, a new class of antimitotic anticancer agents
which inhibit tubulin polymerization. J. Med. Chem. 1990, 33, 1721–1728.
13. Sehlstedt, U.; Aich, P.; Bergman, J.; Vallberg, H.; Norden, B.; Graslund, A. Interactions of the
antiviral quinoxaline derivative 9-OH-B220 [2, 3-dimethyl-6-(dimethylaminoethyl)- 9-hydroxy-6H-
indolo-[2, 3-b]quinoxaline] with duplex and triplex forms of synthetic DNA and RNA. J. Mol. Biol.
1998, 278, 31–56.
14. Ju´nior, J. A.; Schmitt, M.; Antheaume, C.; Bourguignon, J. J. Synthesis of regiospecifically polysubsti-
tuted pyridazinones. Tetrahedron Lett. 2007, 44, 7817–7820.
15. Velentza, A. V.; Wainwright, M. S.; Zasadzki, M.; Mirzoeva, S.; Schumacher, M.; Haiech, J.; Focia, P.
J.; Egli, M.; Waterson, D. M. An aminopyridazine-based inhibitor of a pro-apoptotic protein kinase
attenuates hypoxia-ischemia induced acute brain injury. Bioorg. Med. Chem. Lett. 2003, 13, 3465–3470.
16. a) Wermuth, C. G.; Bourguignon, J. J.; Hoffmann, R.; Boigegrain, R.; Brodin, R.; Kan, J. P.;
Soubrie˙, P. Bioorg. Med. Chem. Lett. 1992, 2, 833–838; b) Contreras, J.M.; Parrot, I.; Sippl, W.;
Rival, Y.M.; Wermuth, C.G. Design, Synthesis, and structure−activity relationships of a series of
3-[2-(1-benzylpiperidin-4-yl)ethylamino]pyridazine derivatives as acetylcholin-esterase inhibitors. J.
Med. Chem. 2001, 44, 2707–2718.
17. Contreras, J. M.; Rival, Y. M.; Chayer, S.; Bourguignon, J. J.; Wermuth, C. G. Aminopyridazines as
acetylcholinesterase inhibitors. J. Med. Chem. 1999, 42, 730–741.
18. Schmitt, M.; Bourguignon, J. J.; Barlin, G. B.; Davies, P. L. Imidazo[1,2-b]pyridazines. XXIV
Syntheses of some 3-(variously substituted) imidazo[1,2-b] pyridazines, 6-substituted 2-benzoyl-
imidazo[1,2-b]pyridazines and pyrimido[1,2-b]pyridazin- 5-ium-3-olates and their interaction with
central and mitochondrial benzodiazepine receptors. Aust. J. Chem. 1997, 50, 779–786.
19. Rival, Y.; Hoffmann, R.; Didier, B.; Rybaltchenko, V.; Bourguign- on, J. J.; Wermuth, C. G. 5-HT3
Antagonists derived from aminopyridazine-type muscarinic M1 Agonists. J. Med. Chem. 1998, 41,
311–317.
20. Corsano, S.; Vezza, R.; Scapicchi, R.; Foresi, S.; Strappaghetti, G.; Nenci, G.; Greele, P. New
pyridazinone derivatives as inhibitors of platelet aggregation. Eur. J. Med. Chem. 1995, 30, 627–631.
21. Betti, L.; Zanelli, M.; Giannaccini, G.; Manetti, F.; Schenone, S.; Strappaghetti, G. Synthesis of new
piperazine-pyridazinone derivatives and their binding affinity toward alpha1-, alpha2-adrenergic and
5-HT1A serotoninergic receptors. Bioorg. Med. Chem. 2006, 14, 2828–2836.
22. Yamada, T.; Nobuhara, Y.; Shimamura, H.; Tsukamoto, Y.; Yoshihara, K.; Yamaguchi, A.; Ohki,
M. Pyridazinones. 2. Synthesis and antisecretory and antiulcer activities of thiourea and 2-
cyanoguanidine derivatives. J. Med. Chem. 1983, 26, 373–381.
23. Murphy, D. E.; Dragovich, P. S.; Ayida, B. K.; Bertolni, T. M.; Li, L. S.; Ruebsam, F.; Stankovic, N.; Sun,
Z.; Zaho, J.; Zhou, Y. Efficient synthesis of 2,6-disubstituted-5-hydroxy-3-oxo-2,3-dihydro-pyridazine-
4-carboxylic acid ethyl esters. Tetrahedron Lett. 2008, 49, 811–815.
24. Pieretti, S.; Dominici, L.; Di Giannuario, A.; Cesari, N.; Dal Piaz, V. Local anti-inflammatory effect
and behavioral studies on new PDE4 inhibitors. Life Sciences 2006, 79, 791–800.
25. Meki, M.; Tomioka, H.; Fujimot, K.; Imahose, T.; Mikya, K. Jpn. Kokai Tokyo Koho, Jp 0245 471
[9045, 741] (C1 C07 D 237118), 15 February 1990; Chem. Abstr. 1990, 113, 54361.